Elevation of nucleocytoplasmic β-N-acetylglucosaminidase (O-GlcNAcase) activity in thyroid cancers

International Journal of Molecular Medicine

Volumn 25, Issue 4, 2010, Pages 643-648

  Krzeslak, Anna ^a   Pomorski, Lech ^b   Lipinska, Anna ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Hexosaminidase; N acetylglucosaminidase; O GlcNAc; Thyroid

Indexed keywords

N ACETYL BETA GLUCOSAMINIDASE;

ANAPLASTIC CARCINOMA; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME METABOLISM; FEMALE; FOLLICULAR CARCINOMA; GOITER; HUMAN; HUMAN CELL; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; THYROID ADENOMA; THYROID CARCINOMA; THYROID CELL; THYROID HYPERPLASIA;

EID: 77749249177     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000387     Document Type: Article

References (28)

1. Dong LY and Hart GW: Purification and characterization of an O-GlcNAc selective N-acetyl-β-D-glucosaminidase from rat spleen cytosol. J Biol Chem 269: 19321-19330, 1994.
2. Neufeld EF: Natural history and inherited disorders of lysosomal enzyme, β-hexosaminidase. J Biol Chem 264: 10927-10930, 1989.
3. Martino S, Emiliani C, Orlacchio A, Hosseini R and Stirling JL: Beta-N-acetyl-hexosaminidases A and S have similar sub-cellular distribution in HL-60 cells. Biochim Biophys Acta 1243: 489-495, 1995.
4. Beutler E: The biochemical genetics of the hexosaminidase system in man. Am J Hum Genet 31: 95-105, 1979.
5. Tutor JC: Biochemical characterization of the GM2 gangliosidosis B1 variant. Braz J Med Biol Res 37: 778-783, 2004.
6. Okochi T, Seike H, Higashino K, et al: Alteration of hexosaminidase isoenzymes in human renal carcinoma. Cancer Res 39: 1829-1834, 1979.
7. Narita M, Taniguchi N, Makita A, Kodama T, Araki E and Oikawa K: Elevated activity of β-hexosaminidase and sulfhydryl modification in the B-variant of human lung cancer. Cancer Res 43: 5037-5042,1983.
8. Gil-Martin E, Gil-Seijo S, Nieto-Novoa C and Fernandez-Briera A: Elevation of acid glycosidase activities in thyroid and gastric tumors. Int J Biochem Cell Biol 28: 651-657, 1996.
9. Gil-Martin E, Rodriguez-Berrocal FJ, Paez de la Cadena M and Fernandez-Briera A: N-acetyl-beta-hexosaminidase activity and isoenzymes in human gastric adenocarcinoma. Oncology 56: 142-154, 1999
10. Luqmani Y, Temmim L, Memon A, et al: Measurment of serum N-acetyl beta glucosaminidase activity in patients with breast cancer. Acta Oncol 38: 649-653, 1999.
11. Oktem F, Yazicilar O, Güvenc MG, Toprak M, Uzun H, Aydin S and Uslu E: Urinary N-acetyl-beta-D-glucosaminidase levels in patients with laryngeal squamous cell carcinoma. J Otolaryngol 36: 233-239, 2007.
12. Wielgat P, Walczuk U, Szajda S, Bien M, Zimnoch L, Mariak Z and Zwierz K: Activity of lysosomal exoglycosidases in human gliomas. J Neurooncol 80: 243-249, 2006.
13. Borzym-Kluczyk M, Olszewska E, Radziejewska I, Lewszuk A and Zwierz K: Isoenzymes of N-acetyl-beta-hexosaminidase in human pleomorphic adenoma and healthy salivary glands: a preliminary study. Clin Chem Lab Med 46: 131-136, 2008.
14. Szajda SD, Snarska J, Jankowska A, Puchalski Z and Zwierz K: Isoenzymes A and B of N-acetyl-beta-D-hexosaminidase in serum and urine of patients with pancreatic cancer. Hepatogastroenterology 55: 695-698, 2008.
15. Olszewska E, Borzym-Kluczyk M, Rzewnicki I, Rutkowska J, Knas M, Rogowski M, Waniewska E and Wielgosz R: Hexosaminidase as a new potential marker for larynx cancer. Clin Biochem 42: 1187-1189, 2009.
16. Yoshida K: Demonstration and some properties of N-acetylbeta-D- hexosaminidase (HEX) C isoenzyme in human renal tissues: relative increase of HEX C activity in renal cell carcinoma. Clin Chim Acta 226: 55-65, 1994.
17. Overdijk B, Van der Kroef WMJ, Veltkamp WA and Hooghwinkel GJM: The separation of bovine brain beta-Nacetyl-D-hexosaminidases. Abnormal gel-filtration behaviour of beta-N-acetyl-D-glucosaminidase C. Biochem J 151: 257-261, 1975.
18. Gao Y, Wells L, Comer FI, Parker GJ and Hart GW: Dynamic O-glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain. J Biol Chem 276: 9838-9845, 2001.
19. Wells L, Gao Y, Mahoney JA, Vosseller K, Chen C, Rosen A and Hart GW: Dynamic O-glycosylation of nuclear and cytosolic proteins. Further characterization of the nucleocytoplasmic β-N-acetylglucosaminidase, O-GlcNAcase. J Biol Chem 277: 1755-1761, 2002.
20. Zachara NE and Hart GW: Cell signaling, the essential role of O-GlcNAc. Biochim Biophys Acta 1761: 599-617, 2006.
21. Dias WB and Hart GW: O-GlcNAc modification in diabetes and Alzheimer's disease. Mol Biosyst 3: 766-772, 2007.
22. Hanover JA: Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J 15: 1865-1876, 2001.
23. Chou TY, Hart GW and Dang CV: C-myc is glycosylated at threonine 58: a known phosphorylation site and a mutational hot spot in lymphomas. J Biol Chem 270: 18961-18965, 1995.
24. Kamemura K, Hayes BK, Comer FI and Hart GW: Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins. Alternative glycosylation/phosphorylation of Thr-58, a known mutational hot spot of c-Myc in lymphomas, is regulated by mitogens. J Biol Chem 277: 19229-19235, 2002.
25. Slawson C, Pidala J and Potter R: Increased N-acetyl-β- glucosaminidase activity in primary breast carcinomas corresponds to a decrease in N-acetylglucosamine containing proteins. Biochim Biophys Acta 1537: 147-157, 2001.
26. Hart GW, Housley MP and Slawson C: Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 446: 1017-1022, 2007.
27. Hanover JA, Krause MW and Love DC: The hexosaminidase signaling pathway: O-GlcNAc cycling in feast or famine. Biochim Biophys Acta (2009), doi: 10.1016/j.bbagen.2009. 07.17.
28. Butkinaree C, Kyoungsook P and Hart GW: O-linked β-N- acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta (2009), doi: 10.1016/j.bbagen.2009.07.18.